In conclusion, anti-TNFα mAb demonstrated the potential to suppress tumor growth, stromal reaction, and angiogenesis, mediate a reduction in the number of TAMs, increase immunity against tumor and apoptosis, and suppress CRC progression in the TME. This evidence concerns the gene TNF and colorectal carcinoma.